Comparison of the Antithrombotic Effects and Bleeding Risk of Fractionated Aurin Tricarboxylic Acid and the GPIIb/IIIa Antagonist GR144053 in a Hamster Model of Stenosis-Reference-Cited by-同舟云学术

Comparison of the Antithrombotic Effects and Bleeding Risk of Fractionated Aurin Tricarboxylic Acid and the GPIIb/IIIa Antagonist GR144053 in a Hamster Model of Stenosis

Published:1999-07 Issue:1 Volume:95 Page:49-61
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Ito Takeshi,Matsuno Hiroyuki,Kozawa Osamu,Niwa Masayuki,Sakai Noboru,Uematsu Toshihiko

Publisher

Elsevier BV

Subject

Hematology

Reference38 articles.

1. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes;Willerson;J Am Coll Cardiol,1986

2. Adjuvant antiplatelet strategies in coronary thrombolysis;Becker;Circulation,1991

3. Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator;Kerins;Circulation,1989

4. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations;Yao;J Am Coll Cardiol,1990

5. Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator;Matsuno;Br J Pharmacol,1992

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet Drugs in the Management of Cerebral Ischemia;Platelets;2019

2. Central Nervous System Ischemia;Platelets;2013

3. Central Nervous System Ischemia;Platelets;2007

4. α2-Antiplasmin on Cardiovascular Diseases;Current Pharmaceutical Design;2006-03-01

5. Role of 2-Antiplasmin in Cardiovascular System;Letters in Drug Design & Discovery;2005-05-01